Unfreezing US FDA: Generic Drug Officials Make Plea For Public Workshops

The FDA generic drugs team’s first public workshop of the second Trump Administration ended with a request that industry amplify the value it finds from public engagement.

OGD wants industry to amplify the perceived value of FDA public meetings. (Shutterstock)

More from Generics

More from User Fees